CoREST复杂抑制改变RNA分裂以促进新抗原表达和增强瘤免疫力
bioRxiv : the preprint server for biology
|December 23, 2024
概括
CoREST抑制器复合体与RNA拼接相互作用,其抑制剂 - - 科林 - - 改变了癌症中的拼接. 这会产生新抗原,增强抗癌免疫力和瘤中的T细胞反应.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 转录条例 转录条例 转录条例
- 癌症免疫学 癌症免疫学
背景情况:
- 表观遗传综合体调节基因表达并与RNA拼接机械相互作用.
- 这些相互作用在癌症中的功能后果尚不清楚.
研究的目的:
- 为了研究CoREST抑制器复合体和RNA拼接因子之间的相互作用.
- 确定这些相互作用在瘤发生和癌症免疫中的功能后果.
主要方法:
- 质谱测量质量谱测量
- 在体内结合测定试验.
- 低温电子显微镜 (cryo-EM) 是一种电子显微镜.
- 预测性机器学习模型
- 在MHC的IP-MS中使用MHC IP-MS.
主要成果:
- 确定了CoREST复合体和RNA拼接因子之间的直接相互作用.
- 科林是一种CoREST抑制剂,扰乱了这些相互作用,导致恶性瘤中广泛的RNA拼接变化.
- 从未注释的拼接部位发现了成千上万的可林诱导新,产生了免疫性拼接新抗原.
- 科林重新激活了免疫检查点阻塞反应,并在免疫冷黑色素瘤模型中扩大了细胞毒性T细胞.
结论:
- 抑制CoREST复合体是一种新的癌症治疗策略.
- 科林治疗产生与瘤相关的新抗原,增强癌症免疫性.
- 这种方法促进了T细胞介导的免疫力,特别是在免疫冷瘤中.
相关概念视频
Alternative RNA Splicing
21.0K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.0K
RNA Splicing
56.0K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.0K
Pre-mRNA Processing: RNA Splicing
5.2K
5.2K
Chromatin Structure and RNA Splicing
2.7K
2.7K
RNA Interference
25.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.9K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K


